Notice: Undefined variable: npDcheckClassBgp in /home/myhealth/typo3/typo3_src-4.2.10_chaire_modif/index.php on line 17 - Others

Evaluating CMR

Metabolic Syndrome and Type 2 Diabetes/CVD Risk



Page: Go to Previous Page 9 of 9 Go to Next Page

  1. Alberti KG and Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
  2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
  3. Chugh A and Bakris GL. Microalbuminuria: what is it? Why is it important? What should be done about it? An update. J Clin Hypertens (Greenwich) 2007; 9: 196-200.
  4. Toft I, Bonaa KH, Eikrem J, et al. Microalbuminuria in hypertension is not a determinant of insulin resistance. Kidney Int 2002; 61: 1445-52.
  5. Pouliot M-C, Després JP, Lemieux S, et al. Waist circumference and abdominal sagitttal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
  6. Hills SA, Balkau B, Coppack SW, et al. The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 2004; 47: 566-70.
  7. Balkau B and Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-3.
  8. Alberti KG, Zimmet P and Shaw J. The metabolic syndrome--a new worldwide definition. Lancet 2005; 366: 1059-62.
  9. Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Blood Press 1998; 7: 262-9.
  10. Farin HM, Abbasi F and Reaven GM. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr 2006; 83: 47-51.
  11. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-52.